Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas J. Fitzgerald, MD"'
Autor:
Joshua P. Schiff, MD, Yimei Lee, MS, Yu Wang, MS, Stephanie M. Perkins, MD, Sandy K. Kessel, MD, Thomas J. Fitzgerald, MD, Nicole A. Larrier, MD, Jeff M. Michalski, MD, MBA
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101083- (2023)
Purpose: Craniospinal irradiation remains an essential and yet difficult part of the treatment of patients with medulloblastoma. Whereas technological advances offer promise of increased conformity, realiance on advanced technology is not without ris
Externí odkaz:
https://doaj.org/article/d7185bfa965f4dd7af1f6b36f9c9c075
Autor:
Raymond B. Mailhot Vega, MD, MPH, Sharon M. Castellino, MD, MSc, Qinglin Pei, PhD, Susan Parsons, MD, MRP, Kenneth B. Roberts, MD, David Hodgson, MD, MPH, Anne-Marie Charpentier, MD, Thomas J. Fitzgerald, MD, Sandy K. Kessel, Frank G. Keller, Kara Kelly, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 3, Pp 55-57 (2021)
Externí odkaz:
https://doaj.org/article/26833359dfdd4977a89be74a7e0e7ed4
Autor:
Peter Lee, BS, Yunsheng Ma, MD, PhD, MPH, Isabel Zacharias, MD, Adel Bozorgzadeh, MD, Sean Wilson, MD, Kim Foley, NP, Paul Rava, MD, PhD, Mark Masciocchi, MD, Linda Ding, PhD, Jacob Bledsoe, MD, Thomas J. Fitzgerald, MD, Shirin Sioshansi, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 889-896 (2020)
Purpose: Our purpose was to report outcomes in patients with Child-Pugh B or C (CP B/C) hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT). Methods and Materials: Patients with HCC suitable for SBRT were prospectiv
Externí odkaz:
https://doaj.org/article/23fa2ffff9bf40cabaf4a08c0cb6e869
Autor:
Rashi Garg, MD, Kimberly Foley, NP, Babak Movahedi, MD, PhD, Mark J. Masciocchi, MD, Jacob R. Bledsoe, MD, Linda Ding, PhD, Paul Rava, MD, PhD, Thomas J. Fitzgerald, MD, Shirin Sioshansi, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100559- (2021)
Purpose: For patients with hepatocellular carcinoma awaiting liver transplantation (LT), stereotactic body radiation therapy (SBRT) has emerged as a bridging treatment to ensure patients maintain priority status and eligibility per Milan criteria. In
Externí odkaz:
https://doaj.org/article/b628fd9be41f40d0a6147dc5d0aee4dc